ArticlePLoS medicine2008

Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.

Tim F Cloughesy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.